Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jul;6(3):539-46.
doi: 10.1016/j.nurt.2009.04.004.

Novel drug delivery strategies in neuro-oncology

Dani S Bidros  1 , Michael A Vogelbaum
Affiliations
Review

Novel drug delivery strategies in neuro-oncology

Dani S Bidros et al. Neurotherapeutics. 2009 Jul.

Abstract

Treatment of malignant gliomas represents one of the most formidable challenges in oncology. Despite treatment with surgery, radiation therapy, and chemotherapy, the prognosis remains poor, particularly for glioblastoma, which has a median survival of 12 to 15 months. An important impediment to finding effective treatments for malignant gliomas is the presence of the blood brain barrier, which serves to prevent delivery of potentially active therapeutic compounds. Multiple efforts are focused on developing strategies to effectively deliver active drugs to brain tumor cells. Blood brain barrier disruption and convection-enhanced delivery have emerged as leading investigational delivery techniques for the treatment of malignant brain tumors. Clinical trials using these methods have been completed, with mixed results, and several more are being initiated. In this review, we describe the clinically available methods used to circumvent the blood brain barrier and summarize the results to date of ongoing and completed clinical trials.

PubMed Disclaimer

References

    1. Central Brain Tumor Registry of the United States (CBTRUS): Statistical report: primary brain tumors in the United States, 2000–2004. Chicago, Central Brain Tumor Registry of the United States, 2005.
    1. Central Nervous System Cancers Practice Guidelines in Oncology. Vol 2. Jenkintown, PA: National Comprehensive Cancer Network; 2005. - PubMed
    1. Nieder C, Grosu AL, Molls M. A comparison of treatment results for recurrent malignant gliomas. Cancer Treatment Rev. 2000;26:397–409. doi: 10.1053/ctrv.2000.0191. - DOI - PubMed
    1. Nicholas MK, Prados MD, Larson DA, Gutin PH, et al. Malignant astrocytomas. In: Black PMCL, Loeffler JS, et al., editors. Cancer of the nervous system. Cambridge: Blackwell Science; 1997. pp. 464–491.
    1. Greenwood J. Experimental manipulation of the blood-brain and blood-retinal barriers. In: Bradbury MWB, editor. the physiology and pharmacology of the blood-brain barrier. Germany: Springer-Verlag; 1992. pp. 459–486.

MeSH terms